7 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Unknown 7 |
Follow Eylea: new trials by email Literature Review of Eylea trials Research Report on Eylea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept aflibercept - Central Serous Chorioretinopathy, Age Related Macular Degeneration | Phase 4 | Unknown | Sunnybrook Health Sciences Centre | 90 | 2018-12-01 | 2021-01-28 |
| Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept Intravitreal aflibercept - Age Related Macular Degeneration, Diabetic Macular Edema | Phase 4 | Unknown | Unity Health Toronto | 168 | 2017-02-28 | 2021-04-28 |
| Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema Aflibercept Injection - Diabetic Macular Edema | Phase 4 | Unknown | Maisonneuve-Rosemont Hospital | 40 | 2016-11-01 | 2017-03-27 |
| Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study aflibercept - Diabetic Macular Edema | Phase 4 | Unknown | Unity Health Toronto | 50 | 2016-03-01 | 2016-01-08 |
| Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration. Aflibercept (EYLEA) - Neovascular Age-related Macular Degeneration | Phase 4 | Unknown | Hadassah Medical Organization | 48 | 2013-10-01 | 2016-01-13 |
| Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy Aflibercept - Retinal Vein Occlusion | Phase 4 | Unknown | Tennessee Retina | 10 | 2013-06-01 | 2014-10-29 |
| On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD) Aflibercept - Age Related Macular Degeneration, Pigment Epithelial Detachment | Phase 4 | Unknown | Tennessee Retina | 30 | 2012-08-01 | 2014-10-29 |
Macular Degeneration (4) · Macular Edema (2) · Retinal Vein Occlusion (2) · Central Serous Chorioretinopathy (1) · Retinal Detachment (1) · Wet Macular Degeneration (1)
Tennessee Retina (2) · Unity Health Toronto (2) · Hadassah Medical Organization (1) · Maisonneuve-Rosemont Hospital (1) · Sunnybrook Health Sciences Centre (1)
Canada (3) · United States (2) · Israel (1)
Brandon G Busbee, MD (1) · Flavio Rezende (1) · Franco M Recchia, MD (1) · Itay Chowers, Prof. (1) · Radha P. Kohly, MD PhD FRCSC (1) · Rajeev Muni (1) · Rajeev Muni, MD (1)